First Quadrant’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-54,755
Closed -$2.22M 672
2019
Q4
$2.22M Sell
54,755
-12,557
-19% -$468K 0.19% 119
2019
Q3
$2.33M Buy
+67,312
New +$2.22M 0.22% 114
2019
Q1
Sell
-2,317
Closed -$72K 786
2018
Q4
$72K Buy
+2,317
New +$84.5K 0.01% 689
2016
Q3
Sell
-2,700
Closed -$150K 901
2016
Q2
$150K Sell
2,700
-32,500
-92% -$1.79M ﹤0.01% 611
2016
Q1
$1.88M Buy
35,200
+23,900
+212% +$1.18M 0.04% 319
2015
Q4
$582K Buy
+11,300
New +$561K 0.01% 457
2014
Q1
Sell
-13,900
Closed -$498K 779
2013
Q4
$498K Hold
13,900
0.01% 463
2013
Q3
$419K Hold
13,900
0.01% 472
2013
Q2
$405K Buy
+13,900
New +$392K 0.01% 464

Other funds holding PBH

First Quadrant's PBH Position: Q1 2020 in Review

First Quadrant sold out of Prestige Consumer Healthcare (PBH) in Q1 2020, closing a stake of 54,755 shares — an estimated $2.22M sold.

First Quadrant first reported a position in PBH in Q2 2013 and held it in 9 quarters. The position peaked at $2.33M in Q3 2019. 251 funds tracked by Wall St. Rank hold PBH as of Q1 2020.

  • First Quadrant reported no remaining Prestige Consumer Healthcare position as of Q1 2020 after selling out during the quarter.
  • First Quadrant sold 54,755 Prestige Consumer Healthcare shares in Q1 2020, an estimated $2.22M.
  • First Quadrant first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 9 quarters.
  • First Quadrant's Prestige Consumer Healthcare position peaked at $2.33M in Q3 2019.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.

Based on First Quadrant's 13F filing for Q1 2020, filed 5 May 2020.